List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 142 studies with search of: "Atazanavir" [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: GS-9350 + atazanavir + emtricitabine/tenofovir DF;   Drug: Comparator: ritonavir + atazanavir + emtricitabine/tenofovir DF
2 Recruiting Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
Conditions: Pediatric HIV;   HIV Infections
Intervention: Drug: Boosted Atazanavir
3 Recruiting Drug Interactions Between Atazanavir Plus Ritonavir Coadministered With Voriconazole in Healthy Subjects
Conditions: Human Immunodeficiency Virus Type 1 (HIV-1);   HIV Infections
Interventions: Drug: Voriconazole;   Drug: Atazanavir;   Drug: Ritonavir
4 Completed
Has Results 		Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
5 Recruiting Switch to Unboosted Atazanavir With Tenofovir Study
Condition: HIV Infection
Interventions: Drug: atazanavir;   Drug: atazanavir/ritonavir
6 Completed
Has Results 		Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression
Condition: Human Immunodeficiency Virus (HIV) Infections
Intervention: Drug: Atazanavir + Ritonavir
7 Completed Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
Conditions: HIV;   HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
8 Completed Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
Condition: HIV Infections
Interventions: Drug: Rosiglitazone maleate;   Drug: Atazanavir Sulphate;   Drug: Atazanavir Sulphate + Rosiglitazone maleate;   Drug: Atazanavir Sulphate + Ritonavir;   Drug: Atazanavir Sulphate + Ritonavir + Rosiglitazone maleate
9 Active, not recruiting Raltegravir and Atazanavir Dosing Strategy Study
Condition: HIV Infection
Intervention: Drug: atazanavir plus raltegravir
10 Recruiting Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
11 Completed Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
Condition: HIV Infections
Interventions: Drug: Atazanavir/ Stavidine / Lamivudine;   Drug: Atazanavir-Ritonavir/ Stavidine / Lamivudine
12 Unknown † Atazanavir and Lamivudine for Treatment Simplification
Condition: HIV Infections
Interventions: Drug: Lamiduvine (Epivir);   Drug: Atazanavir (Reyataz);   Drug: Ritonavir (Norvir)
13 Completed Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
Condition: HIV Infections
Interventions: Drug: Atazanavir+Ritonavir+Tenofovir;   Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine
14 Completed
Has Results 		Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)
Condition: HIV Infections
Interventions: Drug: Atazanavir + 2 NRTIs;   Drug: Atazanavir + Ritonavir + 2 NRTIs
15 Completed Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: raltegravir QD;   Drug: atazanavir;   Drug: lamivudine (or emtricitabine)
16 Completed Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Efavirenz;   Drug: Indinavir/ritonavir;   Drug: Nelfinavir;   Drug: Saquinavir/ritonavir;   Drug: Lopinavir/ritonavir;   Drug: Atazanavir;   Drug: Atazanavir/ritonavir;   Drug: Fos-amprenavir/ritonavir;   Drug: Tipranavir/ ritonavir;   Drug: Darunavir/ritonavir
17 Active, not recruiting PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir
18 Unknown † Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
Condition: HIV Infection
Interventions: Drug: atazanavir arm;   Drug: efavirenz
19 Completed
Has Results 		Metabolic Effects of Switching Kaletra to Boosted Reyataz
Condition: HIV Infections
Interventions: Drug: atazanavir/ritonavir;   Drug: lopinavir/ritonavir
20 Active, not recruiting
Has Results 		Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
Condition: HIV Infections
Interventions: Drug: ritonavir;   Drug: darunavir;   Drug: emtricitabine [FTC]/tenofovir [TDF];   Drug: atazanavir

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services